Kailera Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLRA and other ETFs, options, and stocks.About KLRA
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide.
CEORonald C. Renaud
CEORonald C. Renaud
Employees145
Employees145
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2024
Founded2024
Employees145
Employees145
KLRA Key Statistics
Market cap1.35B
Market cap1.35B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high—
52 Week high—
52 Week low—
52 Week low—
Stock Snapshot
As of today, Kailera Therapeutics(KLRA) shares are valued at $16.00. The company's market cap stands at 1.35B.
On 2026-04-17, Kailera Therapeutics(KLRA) stock opened at —, reached a high of —, and a low of —.
Kailera Therapeutics(KLRA) shares are trading with a volume of 0.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.